Deferred Tax Assets, Valuation Allowance in USD of Vaxxinity, Inc. from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Vaxxinity, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and change rate from Q4 2020 to Q4 2023.
  • Vaxxinity, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2023 was $61.4M, a 24.8% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Vaxxinity, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2023 $61.4M +$12.2M +24.8% 31 Dec 2023 10-K 27 Mar 2024
Q4 2022 $49.2M +$15.1M +44.2% 31 Dec 2022 10-K 27 Mar 2024
Q4 2021 $34.1M +$20.9M +157% 31 Dec 2021 10-K 27 Mar 2023
Q4 2020 $13.2M 31 Dec 2020 10-K 24 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.